先瑞达医疗-B(06669):国家药监局批准RT-ZERO

智通财经
13 Mar 2023

智通财经APP讯,先瑞达医疗-B(06669)发布公告,于2023年3月13日,集团收到中国国家药品监督管理局对RT-Zero(一种高压PTCA球囊,具备低至0.85mm的球囊直径和0.0160”的通过外径,设计用于冠状动脉缺血患者冠脉狭窄部分及慢性全闭塞(CTO)病变的球囊扩张,以改善心肌灌注)的注册批准。公司将适时在中国开展营销活动。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10